Filing search / Wave Life Sciences Ltd. / "Innovate"

424B5

WVE Wave Life Sciences Ltd.

27 Sep 24

Prospectus supplement for primary offering

6:09am

and visibility of our drug substance supply chain, while continuing to innovate oligonucleotide manufacturing. Corporate History and Information We were

424B5

WVE Wave Life Sciences Ltd.

24 Sep 24

Prospectus supplement for primary offering

5:16pm

manufacturing capabilities to increase control and visibility of our drug substance supply chain, while continuing to innovate oligonucleotide

424B5

14i55a9

8 Dec 23

Prospectus supplement for primary offering

6:06am

424B5

a4j51fq0a8w

6 Dec 23

Prospectus supplement for primary offering

4:13pm

424B5

3ycjl q2s1ximnv1

14 Jun 22

Prospectus supplement for primary offering

9:24am